Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.045 CAD Market Closed
Market Cap: 4.4m CAD

Wall Street
Price Targets

VPH Price Targets Summary
Valeo Pharma Inc

There are no price targets for VPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Valeo Pharma Inc Competitors:
Price Targets
DIVISLAB
Divi's Laboratories Ltd
6% Upside
688428
InnoCare Pharma Ltd
78% Upside
CLBIO
Corline Biomedical AB
101% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
21% Upside
4549
Eiken Chemical Co Ltd
12% Downside
BBIO
BridgeBio Pharma Inc
12% Upside
ZYDUSLIFE
Zydus Lifesciences Ltd
13% Upside
1093
CSPC Pharmaceutical Group Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Valeo Pharma Inc

For the last 6 years the compound annual growth rate for Valeo Pharma Inc's revenue is 87%. The projected CAGR for the next 2 years is 14%.

87%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Valeo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Valeo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VPH's stock price target?
Not Available

VPH doesn't have any price targets made by Wall Street professionals.

What is Valeo Pharma Inc's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Valeo Pharma Inc's revenue is 87%. The projected CAGR for the next 2 years is 14%.

Back to Top